Islet cell failure in type 2 diabetes
Open accessThe DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index; none of the 272 sources its claims cite is checked for support yet.
Abstract
The major focus of this Review is on the mechanisms of islet beta cell failure in the pathogenesis of obesity-associated type 2 diabetes (T2D). As this demise occurs within the context of beta cell compensation for insulin resistance, consideration is also given to the mechanisms involved in the compensation process, including mechanisms for expansion of beta cell mass and for enhanced beta cell performance. The importance of genetic, intrauterine, and environmental factors in the determination of "susceptible" islets and overall risk for T2D is reviewed. The likely mechanisms of beta cell failure are discussed within the two broad categories: those with initiation and those with progression roles.
Overview
CoChat Summary
## TL;DR
This is a 2006 review arguing that type 2 diabetes develops when insulin-resistant islets can no longer sustain compensatory b cell function, leading first to dysfunction and then progressive loss of b cell mass. It emphasizes that “susceptible” islets are shaped by genetic, intrauterine, and environmental factors, and that hyperglycemia accelerates damage through glucotoxic and glucolipotoxic mechanisms.
## Key findings
- In longitudinal studies, insulin levels rise during the normoglycemic and prediabetes phases and then decline when fasting glycemia exceeds the upper normal limit of 5.5 mM, marking b cell failure.
- A longitudinal study in Pima Indians found that b cell dysfunction was the major determinant of progression from normoglycemia to diabetes.
- In autopsy pancreata from 124 subjects, the paper reports a 40% and 63% loss of islet b cell volume in obese subjects with impaired fasting glucose and T2D, respectively, compared with weight-matched controls; lean T2D subjects had a 41% loss versus lean controls.
- The paper reports that the STOP-NIDDM trial showed acarbose treatment of IGT subjects reduced the risk of progression to diabetes by 36%.
## Methods
- Narrative review of mechanistic, animal, human postmortem, genetic, and epidemiologic studies on islet b cell compensation and failure in obesity-associated T2D.
- Synthesizes findings from rodent models (including ZF, ZDF, DBA2, GK, and IUGR models) and human islet/pancreas studies, including a transcript profiling study of 7 normal and 5 T2D human islet samples.
- Main analysis is integrative and conceptual: it organizes evidence into mechanisms that promote compensation and mechanisms with initiation versus progression roles in b cell failure.
## Limitations
- The paper states that the mechanisms of b cell compensation are “not fully understood,” and that the role of several proposed factors remains to be established or warrants further investigation.
- It explicitly notes uncertainty about several mechanisms, including whether nonimmune islet inflammation contributes in vivo, whether IAPP is causal in b cell dysfunction and demise, and whether reduced ARNT expression is an early defect or a consequence.
- Evident from the text: this is a review, not a new experimental study, so its conclusions depend on the quality and consistency of the cited animal and human studies rather than on a single primary dataset.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 1 Not valid · 164 Not checked · 38 Own results and interpretations
In the paper
“Longitudinal studies of subjects that develop T2D show a rise in insulin levels in the normoglycemic and prediabetes phases that keep glycemia near normal despite the insulin resistance ( b cell compensation), followed by a decline when fasting glycemia surpasses the upper limit of normal of 5.5 mM ( b cell failure) (5) (Figure 1).”
What the sources say
- Not checked yetcites [5]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“With respect to the latter, increases were observed in enzymes and metabolites involved in anaplerosis and the malate-pyruvate and citratepyruvate shuttles of ZF islets (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Inhibition of these pathways by phenylacetic acid, which inhibits PC, markedly impeded GSIS (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Studies of islet b cell compensation within models that maintain normoglycemia show upregulation of glucose metabolism pathways (12, 13, 31).”
What the sources say
- Not checked yetcites [12]
- Not checked yetcites [13]
- Not checked yetcites [31]
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A recent study in Zucker fatty (ZF) rats has provided strong support for PKB activation in the b cell growth response to insulin resistance in this normoglycemic model (11).”
What the sources say
- Not checked yetcites [11]
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
116 more claims
Create a free account to see all 203 claims and to verify the 272 references still open.
- It may state two separate claims as one. 71
- Probably not a substantial claim. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, several of these studies have demonstrated that fatty acids do not induce beta-cell dysfunction in the absence of elevated glucose, highlighting that fatty acids and glucose are not cytotoxic independently.168,169”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [169]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, impairment of insulin secretion in the presence of an intact β-cell mass also occurs in the early stages of human age-related diabetes123.”
From The telomere syndromes (2012) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [75]
Experimental — accuracy not yet measured
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Barker, D. J. P., Hales, C. N., Fall, C. H. D., Osmond, C., Phipps, K., & Clark, P. M. S. (1993) · Diabetologia · doi:10.1007/bf00399095 · Cited by 2,468
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., et al. (2003) · Nature · doi:10.1038/nature01478 · Cited by 1,538
Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
Deeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L., Kuusisto, J., Laakso, M., Fujimoto, W., & Auwerx, J. (1998) · Nature Genetics · doi:10.1038/3099 · Cited by 1,319
Martin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158
Robertson, R. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400019200 · Cited by 1,078
Fryer, L. G. D., Parbu-Patel, A., & Carling, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202489200 · Cited by 1,029
Tomas, E., Tsao, T.-S., Saha, A. K., Murrey, H. E., Zhang, C. C., Itani, S. I., Lodish, H. F., & Ruderman, N. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222657499 · Cited by 973
Autonomic regulation of islet hormone secretion - Implications for health and disease
Ahrén, B. (2000) · Diabetologia · doi:10.1007/s001250051322 · Cited by 909
Lee, Y., Hirose, H., Ohneda, M., Johnson, J. H., McGarry, J. D., & Unger, R. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10878 · Cited by 836
Du, X., Matsumura, T., Edelstein, D., Rossetti, L., Zsengellér, Z., Szabó, C., & Brownlee, M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18127 · Cited by 832
Gloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Poitout, V., & Robertson, R. P. (2002) · Endocrinology · doi:10.1210/endo.143.2.8623 · Cited by 743
Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea
Yoon, K. H., Ko, S. H., Cho, J. H., Lee, J. M., Ahn, Y. B., Song, K. H., Yoo, S. J., Kang, M. I., Cha, B. Y., Lee, K. W., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020735 · Cited by 649
Lupi, R., Dotta, F., Marselli, L., Del Guerra, S., Masini, M., Santangelo, C., Patané, G., Boggi, U., Piro, S., Anello, M., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1437 · Cited by 595
Saturated Fatty Acids Synergize with Elevated Glucose to Cause Pancreatic β-Cell Death
El-Assaad, W., Buteau, J., Peyot, M.-L., Nolan, C., Roduit, R., Hardy, S., Joly, E., Dbaibo, G., Rosenberg, L., & Prentki, M. (2003) · Endocrinology · doi:10.1210/en.2003-0410 · Cited by 587
Self-citationCnop, M., Hannaert, J. C., Hoorens, A., Eizirik, D. L., & Pipeleers, D. G. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1771 · Cited by 549
Maedler, K., Oberholzer, J., Bucher, P., Spinas, G. A., & Donath, M. Y. (2003) · Diabetes · doi:10.2337/diabetes.52.3.726 · Cited by 549
cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2
Jhala, U. S., Canettieri, G., Screaton, R. A., Kulkarni, R. N., Krajewski, S., Reed, J., Walker, J., Lin, X., White, M., & Montminy, M. (2003) · Genes & Development · doi:10.1101/gad.1097103 · Cited by 543
Endoplasmic reticulum stress-mediated apoptosis in pancreatic β-cells
Oyadomari, S., Araki, E., & Mori, M. (2002) · Apoptosis · doi:10.1023/a:1016175429877 · Cited by 517
Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis
Maechler, P., & Wollheim, C. B. (1999) · Nature · doi:10.1038/45280 · Cited by 507
Pancreatic islet glucose metabolism and regulation of insulin secretion
Meglasson, M. D., & Matschinsky, F. M. (1986) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610020301 · Cited by 499
Gunton, J. E., Kulkarni, R. N., Yim, S., Okada, T., Hawthorne, W. J., Tseng, Y.-H., Roberson, R. S., Ricordi, C., O’Connell, P. J., Gonzalez, F. J., et al. (2005) · Cell · doi:10.1016/j.cell.2005.05.027 · Cited by 492
Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover.
Unger, R. H., & Zhou, Y. T. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s118 · Cited by 482
Pathogenesis of Type 2 Diabetes Mellitus
Leahy, J. L. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.003 · Cited by 469
Prentki, M., & Corkey, B. E. (1996) · Diabetes · doi:10.2337/diab.45.3.273 · Cited by 469
Self-citationFu, M.-X., Wells-Knecht, K. J., Blackledge, J. A., Lyons, T. J., Thorpe, S. R., & Baynes, J. W. (1994) · Diabetes · doi:10.2337/diab.43.5.676 · Cited by 464
AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome
Ruderman, N., & Prentki, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1344 · Cited by 451
Self-citationMechanisms of β-Cell Death in Type 2 Diabetes
Donath, M. Y., Ehses, J. A., Maedler, K., Schumann, D. M., Ellingsgaard, H., Eppler, E., & Reinecke, M. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s108 · Cited by 444
Malonyl-CoA Signaling, Lipid Partitioning, and Glucolipotoxicity
Prentki, M., Joly, E., El-Assaad, W., & Roduit, R. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s405 · Cited by 431
Self-citationSteneberg, P., Rubins, N., Bartoov-Shifman, R., Walker, M. D., & Edlund, H. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.03.007 · Cited by 411
Buteau, J., Foisy, S., Joly, E., & Prentki, M. (2003) · Diabetes · doi:10.2337/diabetes.52.1.124 · Cited by 411
Self-citationSuperoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction
Krauss, S., Zhang, C.-Y., Scorrano, L., Dalgaard, L. T., St-Pierre, J., Grey, S. T., & Lowell, B. B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319774 · Cited by 401
Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction
Krauss, S., Zhang, C.-Y., Scorrano, L., Dalgaard, L. T., St-Pierre, J., Grey, S. T., & Lowell, B. B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19774 · Cited by 394
Glucose Induces β-Cell Apoptosis Via Upregulation of the Fas Receptor in Human Islets
Maedler, K., Spinas, G. A., Lehmann, R., Sergeev, P., Weber, M., Fontana, A., Kaiser, N., & Donath, M. Y. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1683 · Cited by 367
Regulation of insulin gene transcription
Melloul, D., Marshak, S., & Cerasi, E. (2002) · Diabetologia · doi:10.1007/s00125-001-0728-y · Cited by 358
Structural and Functional Abnormalities in the Islets Isolated From Type 2 Diabetic Subjects
Deng, S., Vatamaniuk, M., Huang, X., Doliba, N., Lian, M.-M., Frank, A., Velidedeoglu, E., Desai, N. M., Koeberlein, B., Wolf, B., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.3.624 · Cited by 349
Miyata, T., Inagi, R., Iida, Y., Sato, M., Yamada, N., Oda, O., Maeda, K., & Seo, H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117002 · Cited by 345
High Glucose Causes Apoptosis in Cultured Human Pancreatic Islets of Langerhans
Federici, M., Hribal, M., Perego, L., Ranalli, M., Caradonna, Z., Perego, C., Usellini, L., Nano, R., Bonini, P., Bertuzzi, F., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1290 · Cited by 333
Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.
Rossetti, L., Shulman, G. I., Zawalich, W., & DeFronzo, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113157 · Cited by 330
Kaneto, H., Xu, G., Song, K.-H., Suzuma, K., Bonner-Weir, S., Sharma, A., & Weir, G. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104115200 · Cited by 327
Coleman, R. A., Lewin, T. M., Van Horn, C. G., & Gonzalez-Baró, M. R. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.8.2123 · Cited by 304
Neve, B., Fernandez-Zapico, M. E., Ashkenazi-Katalan, V., Dina, C., Hamid, Y. H., Joly, E., Vaillant, E., Benmezroua, Y., Durand, E., Bakaher, N., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409177102 · Cited by 293
Self-citationEk, J., Andersen, G., Urhammer, S. A., Gæde, P. H., Drivsholm, T., Borch-Johnsen, K., Hansen, T., & Pedersen, O. (2001) · Diabetologia · doi:10.1007/s001250100032 · Cited by 293
Feasibility of a Mitochondrial Pyruvate Malate Shuttle in Pancreatic Islets
MacDonald, M. J. (1995) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94588-6 · Cited by 273
Saturated Fatty Acid-induced Apoptosis in MDA-MB-231 Breast Cancer Cells
Hardy, S., El-Assaad, W., Przybytkowski, E., Joly, E., Prentki, M., & Langelier, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300190200 · Cited by 270
Self-citationButler, A. E., Jang, J., Gurlo, T., Carty, M. D., Soeller, W. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1509 · Cited by 267
Farfari, S., Schulz, V, Corkey, B., & Prentki, M. (2000) · Diabetes · doi:10.2337/diabetes.49.5.718 · Cited by 266
Self-citationHummel, K. P., Coleman, D. L., & Lane, P. W. (1972) · Biochemical Genetics · doi:10.1007/bf00487005 · Cited by 263
(1998) · PubMed · Cited by 239
Lameloise, N., Muzzin, P., Prentki, M., & Assimacopoulos-Jeannet, F. (2001) · Diabetes · doi:10.2337/diabetes.50.4.803 · Cited by 229
Self-citationDominant Negative Pathogenesis by Mutant Proinsulin in the Akita Diabetic Mouse
Izumi, T., Yokota-Hashimoto, H., Zhao, S., Wang, J., Halban, P. A., & Takeuchi, T. (2003) · Diabetes · doi:10.2337/diabetes.52.2.409 · Cited by 214
A radical explanation for glucose-induced β cell dysfunction
Brownlee, M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320501 · Cited by 212
Protection against lipoapoptosis of β cells through leptin-dependent maintenance of Bcl-2 expression
Shimabukuro, M., Wang, M.-Y., Zhou, Y.-T., Newgard, C. B., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9558 · Cited by 212
Islet amyloid polypeptide and type 2 diabetes
Marzban, L. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00004-4 · Cited by 201
Du, X., Matsumura, T., Edelstein, D., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318127 · Cited by 200
Simmons, R. A., Suponitsky-Kroyter, I., & Selak, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505695200 · Cited by 194
Roduit, R., Nolan, C., Alarcon, C., Moore, P., Barbeau, A., Delghingaro-Augusto, V., Przybykowski, E., Morin, J., Massé, F., Massie, B., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1007 · Cited by 192
Self-citationNew insights into pancreatic β-cell metabolic signaling in insulin secretion
Prentki, M. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1340272 · Cited by 192
Self-citationThe Islet β Cell-enriched MafA Activator Is a Key Regulator of Insulin Gene Transcription
Zhao, L., Guo, M., Matsuoka, T.-A., Hagman, D. K., Parazzoli, S. D., Poitout, V., & Stein, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409475200 · Cited by 190
Increased Lipogenic Capacity of the Islets of Obese Rats: A Role in the Pathogenesis of NIDDM
Lee, Y., Hiros, H., Zhou, Y.-T., Esser, V., McGarry, J. D., & Unger, R. H. (1997) · Diabetes · doi:10.2337/diab.46.3.408 · Cited by 185
Weedon, M. N., Schwarz, P. E. H., Horikawa, Y., Iwasaki, N., Illig, T., Holle, R., Rathmann, W., Selisko, T., Schulze, J., Owen, K. R., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/379285 · Cited by 184
Busch, A. K., Gurisik, E., Cordery, D. V., Sudlow, M., Denyer, G. S., Laybutt, D. R., Hughes, W. E., & Biden, T. J. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2917 · Cited by 183
Maestre, I., Jordán, J., Calvo, S., Reig, J. A., Ceña, V., Soria, B., Prentki, M., & Roche, E. (2003) · Endocrinology · doi:10.1210/en.2001-211282 · Cited by 182
Self-citationOleate Promotes the Proliferation of Breast Cancer Cells via the G Protein-coupled Receptor GPR40
Hardy, S., St-Onge, G. G., Joly, É., Langelier, Y., & Prentki, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410922200 · Cited by 175
Self-citationNolan, C. J., Leahy, J. L., Delghingaro‐Augusto, V., Moibi, J. A., Soni, K. G., Peyot, M., Fortier, M., Guay, C., Lamontagne, J., Barbeau, A., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0305-5 · Cited by 171
Self-citationMechanisms of Compensatory β-Cell Growth in Insulin-Resistant Rats
Jetton, T. L., Lausier, J., LaRock, K., Trotman, W. E., Larmie, B., Habibovic, A., Peshavaria, M., & Leahy, J. L. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2294 · Cited by 171
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
Larter, C. Z., & Farrell, G. C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.030 · Cited by 169
β-Cell Adaptation to Insulin Resistance
Liu, Y. Q., Jetton, T. L., & Leahy, J. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207157200 · Cited by 165
Adaptation of β-cell mass to substrate oversupply: enhanced function with normal gene expression
Steil, G. M., Trivedi, N., Jonas, J.-C., Hasenkamp, W. M., Sharma, A., Bonner-Weir, S., & Weir, G. C. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e788 · Cited by 162
Postprandial glucose regulation: New data andnew implications
Leiter, L. A., Ceriello, A., Davidson, J. A., Hanefeld, M., Monnier, L., Owens, D. R., Tajima, N., & Tuomilehto, J. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.11.020 · Cited by 161
Dobbins, R. L., Chester, M. W., Stevenson, B. E., Daniels, M. B., Stein, D. T., & McGarry, J. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1813 · Cited by 161
Yu, X., McCorkle, S. K., Wang, M., Lee, Y., Li, J., Saha, A. K., Unger, R. H., & Ruderman, N. B. (2004) · Diabetologia · doi:10.1007/s00125-004-1570-9 · Cited by 160
The insulin gene VNTR, type 2 diabetes and birth weight
Ong, K. K. L., Phillips, D. I., Fall, C., Poulton, J., Bennett, S. T., Golding, J., Todd, J. A., & Dunger, D. B. (1999) · Nature Genetics · doi:10.1038/6775 · Cited by 158
Critical Reduction in β-Cell Mass Results in Two Distinct Outcomes over Time
Laybutt, D. R., Glandt, M., Xu, G., Ahn, Y. B., Trivedi, N., Bonner-Weir, S., & Weir, G. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210581200 · Cited by 156
Beta-cell function improved by supplementing basal insulin secretion in mild diabetes.
Turner, R. C., McCarthy, S. T., Holman, R. R., & Harris, E. (1976) · BMJ · doi:10.1136/bmj.1.6020.1252 · Cited by 151
Porte, Jr. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200105/06)17:3<181::aid-dmrr197>3.0.co;2-1 · Cited by 141
Harmon, J. S., Gleason, C. E., Tanaka, Y., Poitout, V., & Robertson, R. P. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2481 · Cited by 140
Glucose Suppresses Superoxide Generation in Metabolically Responsive Pancreatic β Cells
Martens, G. A., Cai, Y., Hinke, S., Stangé, G., Van de Casteele, M., & Pipeleers, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411869200 · Cited by 138
Åhrén, B., Simonsson, E., Scheurink, A. J. W., Mulder, H., Myrsén-Axcrona, U., & Sundler, F. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90175-x · Cited by 138
Boucher, A., Lu, D., Burgess, S. C., Telemaque-Potts, S., Jensen, M. V., Mulder, H., Wang, M.-Y., Unger, R. H., Sherry, A. D., & Newgard, C. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401167200 · Cited by 136
Andrikopoulos, S., Massa, C. M., Aston-Mourney, K., Funkat, A., Fam, B. C., Hull, R. L., Kahn, S. E., & Proietto, J. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06333 · Cited by 133
Laedtke, T., Kjems, L., Pørksen, N., Schmitz, O., Veldhuis, J., Kao, P. C., & Butler, P. C. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.3.e520 · Cited by 133
Loss of beta cell function as fasting glucose increases in the non-diabetic range
Godsland, I. F., Jeffs, J. A. R., & Johnston, D. G. (2004) · Diabetologia · doi:10.1007/s00125-004-1454-z · Cited by 131
Moffitt, J. H., Fielding, B. A., Evershed, R. P., Berstan, R., Currie, J. M., & Clark, A. (2005) · Diabetologia · doi:10.1007/s00125-005-1861-9 · Cited by 126
Role of the forkhead protein FoxO1 in cell compensation to insulin resistance
Okamoto, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24967 · Cited by 125
β-Cell Secretory Dysfunction in the Pathogenesis of Low Birth Weight–Associated Diabetes
Jimenez-Chillaron, J. C., Hernandez-Valencia, M., Reamer, C., Fisher, S., Joszi, A., Hirshman, M., Oge, A., Walrond, S., Przybyla, R., Boozer, C., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.3.702 · Cited by 123
13C NMR Isotopomer Analysis of Anaplerotic Pathways in INS-1 Cells
Cline, G. W., LePine, R. L., Papas, K. K., Kibbey, R. G., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311842200 · Cited by 122
Fu, M.-X., Wells-Knecht, K. J., Blackledge, J. A., et al. (1994) · Diabetes · doi:10.2337/diabetes.43.5.676 · Cited by 122
IMPROVEMENT IN INSULIN SECRETION IN DIABETES AFTER DIAZOXIDE
Greenwood, R. H., Mahler, R., & Hales, C. N. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91473-2 · Cited by 118
Glucose promotes pancreatic islet β-cell survival through a PI 3-kinase/Akt-signaling pathway
Srinivasan, S., Bernal-Mizrachi, E., Ohsugi, M., & Permutt, M. A. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00177.2002 · Cited by 117
Kiba, T., Tanaka, K., Numata, K., Hoshino, M., Misugi, K., & Inoue, S. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8608899 · Cited by 116
Magnan, C., Collins, S., Berthault, M.-F., Kassis, N., Vincent, M., Gilbert, M., Pénicaud, L., Ktorza, A., & Assimacopoulos-Jeannet, F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3883 · Cited by 115
O'Brien, T. D., Butler, P. C., Westermark, P., & Johnson, K. H. (1993) · Veterinary Pathology · doi:10.1177/030098589303000401 · Cited by 115
Wicksteed, B., Alarcon, C., Briaud, I., Lingohr, M. K., & Rhodes, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303509200 · Cited by 114
A Genetic Defect in β-Cell Gene Expression Segregates Independently From the fa Locus in the ZDF Rat
Griffen, S. C., Wang, J., & German, M. S. (2001) · Diabetes · doi:10.2337/diabetes.50.1.63 · Cited by 110
Prentki, M., & Corkey, B. E. (1996) · Diabetes · doi:10.2337/diabetes.45.3.273 · Cited by 108
Self-citationCandidate Genes for Type 2 Diabetes
Parikh, H. M., & Groop, L. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000021437.46773.26 · Cited by 102
Funkat, A., Massa, C. M., Jovanovska, V., Proietto, J., & Andrikopoulos, S. (2004) · Journal of Nutrition · doi:10.1093/jn/134.12.3264 · Cited by 95
Intra-uterine Transmission of Disease
Aerts, L., & Assche, F. A. V. (2003) · Placenta · doi:10.1016/s0143-4004(03)00115-2 · Cited by 85
Genetic and clinical characteristics of maturity‐onset diabetes of the young
Giuffrida, F. M. A., & Reis, A. F. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00399.x · Cited by 85
Chen, C., Hosokawa, H., Bumbalo, L. M., & Leahy, J. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117335 · Cited by 82
MacDonald, M. J., Efendic, S., & Ostenson, C.-G. (1996) · Diabetes · doi:10.2337/diab.45.7.886 · Cited by 82
Kooptiwut, S., Zraika, S., Thorburn, A. W., Dunlop, M. E., Darwiche, R., Kay, T. W., Proietto, J., & Andrikopoulos, S. (2002) · Endocrinology · doi:10.1210/endo.143.6.8859 · Cited by 79
Peyot, M.-L., Nolan, C. J., Soni, K., Joly, E., Lussier, R., Corkey, B. E., Wang, S. P., Mitchell, G. A., & Prentki, M. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1733 · Cited by 77
Self-citationInhibition of Lipase Activity and Lipolysis in Rat Islets Reduces Insulin Secretion
Mulder, H., Yang, S., Winzell, M. S., Holm, C., & Åhrén, B. (2004) · Diabetes · doi:10.2337/diabetes.53.1.122 · Cited by 75
Insulin‐like growth factors and pancreas beta cells
van Haeften, T. W., & Twickler, T. B. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01337.x · Cited by 71
MacDonald, M. J., Tang, J., & Polonsky, K. S. (1996) · Diabetes · doi:10.2337/diab.45.11.1626 · Cited by 68
The redox regulation of intermediary metabolism by a superoxide–aconitase rheostat
Armstrong, J. S., Whiteman, M., Yang, H., & Jones, D. P. (2004) · BioEssays · doi:10.1002/bies.20071 · Cited by 61
Psammomys Obesus, a Model for Environment-Gene Interactions in Type 2 Diabetes
Kaiser, N., Nesher, R., Donath, M. Y., Fraenkel, M., Behar, V., Magnan, C., Ktorza, A., Cerasi, E., & Leibowitz, G. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s137 · Cited by 60
Regulation of the Pancreatic Duodenal Homeobox-1 Protein by DNA-dependent Protein Kinase
Lebrun, P., Montminy, M., & OBBERGHEN, E. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504842200 · Cited by 53
Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM
Lee, Y., Hirose, H., Zhou, Y. T., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.3.408 · Cited by 47
Liu, Y. Q., Tornheim, K., & Leahy, J. L. (1999) · Diabetes · doi:10.2337/diabetes.48.9.1747 · Cited by 46
Winzell, M. S., Svensson, H. P., Arner, P., Åhrén, B., & Holm, C. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2225 · Cited by 46
Increased Catalytic Activity of Glucokinase in Isolated Islets From Hyperinsulinemic Rats
Chen, C., Bumbalo, L. M., & Leahy, J. L. (1994) · Diabetes · doi:10.2337/diab.43.5.684 · Cited by 45
Iizuka, K., Nakajima, H., Namba, M., Miyagawa, J.-I., Miyazaki, J., Hanafusa, T., & Matsuzawa, Y. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00082-5 · Cited by 43
Van Citters, G. W., Kabir, M., Kim, S. P., Mittelman, S. D., Dea, M. K., Brubaker, P. L., & Bergman, R. N. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020002 · Cited by 43
Stefan, N., Stumvoll, M., Bogardus, C., & Tataranni, P. A. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00427.2002 · Cited by 42
Minn, A. H., Hong, L., Rabaglia, M. E., Harlan, D. M., Peculis, B. A., Attie, A., & Shalev, A. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0119 · Cited by 42
Rió, G. D., Massimo, P., Bondi, M., Marrama, P., Menozzi, R., Oleandri, S. E., Grottoli, S., Maccario, M., Velardo, A., & Ghigo, E. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800523 · Cited by 33
Narita, R., Toshimori, H., Nakazato, M., Kuribayashi, T., Toshimori, T., Kawabata, K., Takahashi, K., & Masukura, S. (1992) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(92)90060-5 · Cited by 29
MacDonald, M. J., Efendic, S., & Ostenson, C. G. (1996) · Diabetes · doi:10.2337/diabetes.45.7.886 · Cited by 18
MacDonald, M. J., Tang, J., & Polonsky, K. S. (1996) · Diabetes · doi:10.2337/diabetes.45.11.1626 · Cited by 17
MacDonald, M. J. (1996) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82583-2 · Cited by 14
Increased catalytic activity of glucokinase in isolated islets from hyperinsulinemic rats
Chen, C.-F., Bumbalo, L., & Leahy, J. L. (1994) · Diabetes · doi:10.2337/diabetes.43.5.684 · Cited by 10
Cited by
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
The Pathophysiology of Gestational Diabetes Mellitus
Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113342 · Cited by 1,874
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
BackgroundMoringa oleifera: A review on nutritive importance and its medicinal application
Gopalakrishnan, L., Doriya, K., & Kumar, D. S. (2016) · Food Science and Human Wellness · doi:10.1016/j.fshw.2016.04.001 · Cited by 1,374
The Role for Endoplasmic Reticulum Stress in Diabetes Mellitus
Eizirik, D. L., Cardozo, A. K., & Cnop, M. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0015 · Cited by 1,173
Metadata
- Authors
- Prentki, M.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Corresponding author
- Prentki, M.
- ORCID
- Prentki, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-07-03
- Volume
- 116
- Issue
- 7
- Pages
- 1802-1812
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1483155
- OpenAlex
- W1598254642
- Cited by
- 1,690
- References
- 132
- Citations by year
- 2026: 52 · 2025: 52 · 2024: 46 · 2023: 54 · 2022: 68 · 2021: 95 · 2020: 95 · 2019: 111 · 2018: 90 · 2017: 109 · 2016: 112 · 2015: 107 · 2014: 131 · 2013: 97 · 2012: 98
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Funders
- ACT Government
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK063356, DK63356)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- beta-cell failure, type 2 diabetes, obesity, beta-cell compensation, beta-cell mass expansion, insulin resistance, genetic susceptibility, intrauterine factors, environmental risk factors, beta-cell dysfunction
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Disease Progression, Genetic Predisposition to Disease, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.